Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-21-000564
Filing Date
2021-10-06
Accepted
2021-10-06 16:19:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 diamedicatherapeutics13g.htm SC 13G 29726
  Complete submission text file 0000935836-21-000564.txt   31054
Mailing Address 467 CPW NY NY 10025
Business Address
LYTTON LAURENCE W (Filed by) CIK: 0001105806 (see all company filings)

Type: SC 13G

Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Subject) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90788 | Film No.: 211309963
SIC: 2834 Pharmaceutical Preparations